Keith Higgins

679 total citations
14 papers, 552 citations indexed

About

Keith Higgins is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Keith Higgins has authored 14 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Virology, 10 papers in Immunology and 4 papers in Infectious Diseases. Recurrent topics in Keith Higgins's work include HIV Research and Treatment (12 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (3 papers). Keith Higgins is often cited by papers focused on HIV Research and Treatment (12 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (3 papers). Keith Higgins collaborates with scholars based in United States, Switzerland and Tanzania. Keith Higgins's co-authors include Nancy L. Haigwood, Kathelyn S. Steimer, Gary Ott, C George-Nascimento, G A Van Nest, Peter L. Nara, Ellena Brooks, J. W. Eichberg, Carl J. Scandella and Nancy M. Dunlop and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Virology and Scientific Reports.

In The Last Decade

Keith Higgins

14 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith Higgins United States 11 368 224 173 153 153 14 552
Els J. M. Hogervorst Netherlands 11 291 0.8× 252 1.1× 277 1.6× 127 0.8× 287 1.9× 13 721
Michael Tuen United States 17 488 1.3× 469 2.1× 163 0.9× 134 0.9× 219 1.4× 33 773
Thandavarayan Nagashunmugam United States 14 222 0.6× 199 0.9× 133 0.8× 313 2.0× 114 0.7× 25 624
Bruce J. Bernacky United States 7 693 1.9× 492 2.2× 200 1.2× 260 1.7× 270 1.8× 14 965
Kathie Grovit‐Ferbas United States 14 894 2.4× 549 2.5× 228 1.3× 306 2.0× 464 3.0× 15 1.2k
K. E. Schneweis Germany 13 221 0.6× 266 1.2× 115 0.7× 568 3.7× 173 1.1× 39 835
Mark A. Luscher Canada 14 410 1.1× 679 3.0× 160 0.9× 159 1.0× 174 1.1× 21 931
Michael H. Newberg United States 16 307 0.8× 509 2.3× 253 1.5× 207 1.4× 184 1.2× 16 860
William F. Sutton United States 16 468 1.3× 425 1.9× 162 0.9× 237 1.5× 224 1.5× 22 832
Eung‐Jun Im United Kingdom 11 351 1.0× 414 1.8× 270 1.6× 111 0.7× 169 1.1× 13 652

Countries citing papers authored by Keith Higgins

Since Specialization
Citations

This map shows the geographic impact of Keith Higgins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Higgins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Higgins more than expected).

Fields of papers citing papers by Keith Higgins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Higgins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Higgins. The network helps show where Keith Higgins may publish in the future.

Co-authorship network of co-authors of Keith Higgins

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Higgins. A scholar is included among the top collaborators of Keith Higgins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Higgins. Keith Higgins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Royo, José Luís, Francisco J. Márquez, Mohamed Omar, et al.. (2019). Association of complement C3d receptor 2 genotypes with the acquisition of HIV infection in a trial of recombinant glycoprotein 120 vaccine. AIDS. 34(1). 25–32. 7 indexed citations
2.
Balasubramanian, Preetha, Constance Williams, Faruk Sinangil, et al.. (2018). Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine Trials. Scientific Reports. 8(1). 542–542. 19 indexed citations
3.
Balasubramanian, Preetha, Rajnish Kumar, Constance Williams, et al.. (2017). Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccination. Vaccine. 35(10). 1464–1473. 10 indexed citations
4.
Krueger, N., Isaac R. Rodriguez‐Chavez, Michael P. Busch, et al.. (2014). Performance of a Redesigned HIV Selectest Enzyme-Linked Immunosorbent Assay Optimized To Minimize Vaccine-Induced Seropositivity in HIV Vaccine Trial Participants. Clinical and Vaccine Immunology. 21(3). 391–398. 13 indexed citations
5.
Empig, Cyril, Julie Kenner, Edward F. Bell, et al.. (2005). Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge. Vaccine. 24(17). 3686–3694. 46 indexed citations
6.
O’Hagan, Derek T., Mildred Ugozzoli, Manmohan Singh, et al.. (2000). Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1. Vaccine. 18(17). 1793–1801. 29 indexed citations
7.
Jelonek, Marie T., et al.. (1996). Maternal Monoclonal Antibody to the V3 Loop Alters Specificity of the Response to a Human Immunodeficiency Virus Vaccine. The Journal of Infectious Diseases. 174(4). 866–869. 7 indexed citations
8.
MURTHY, KRISHNA K., Keith Higgins, E K Cobb, et al.. (1995). Resistance of chimpanzees immunized with recombinant gp120SF2 to challenge by HIV-1SF2. AIDS. 9(12). 1313–1322. 39 indexed citations
9.
Jelonek, Marie T., et al.. (1995). Inhibition of the Offspring Anti-Recombinant gp120 Antibody Response to a Human Immunodeficiency Virus Vaccine by Maternal Immunization in a Murine Model. The Journal of Infectious Diseases. 172(2). 539–542. 5 indexed citations
10.
Haigwood, Nancy L., Peter L. Nara, Ellena Brooks, et al.. (1992). Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons. Journal of Virology. 66(1). 172–182. 123 indexed citations
11.
Klinman, Dennis M., Keith Higgins, & Jacqueline Conover. (1991). Sequential immunizations with rgp120s from independent isolates of human immunodeficiency virus type 1 induce the preferential expansion of broadly crossreactive B cells.. The Journal of Experimental Medicine. 173(4). 881–887. 27 indexed citations
12.
Haigwood, Nancy L., Jeffrey R. Shuster, Helen Lee, et al.. (1990). Importance of Hypervariable Regions of HIV-1 gp120 in the Generation of Virus Neutralizing Antibodies. AIDS Research and Human Retroviruses. 6(7). 855–869. 86 indexed citations
13.
Steimer, Kathelyn S., Keith Higgins, Maureen A. Powers, et al.. (1986). Recombinant polypeptide from the endonuclease region of the acquired immune deficiency syndrome retrovirus polymerase (pol) gene detects serum antibodies in most infected individuals. Journal of Virology. 58(1). 9–16. 62 indexed citations
14.
Brown, Caroline, Keith Higgins, Kelly A. Frazer, et al.. (1985). Simultaneous determination of total IgE and allergen-specific IgE in serum by the MAST chemiluminescent assay system.. Clinical Chemistry. 31(9). 1500–1505. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026